A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
Clinical trial NCT02815267 · COMPLETED
Trial details
- NCT number
- NCT02815267
- Sponsor
- Vyne Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2017-10-13
- Enrollment
- 466
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.